首页> 外文期刊>Indian Journal of Radiology and Imaging >Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
【24h】

Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers

机译:强迫利尿和双相18F-氟脱氧葡萄糖PET / CT扫描可重新分期诊断膀胱癌

获取原文
       

摘要

Context: The results of 18F-fluorodeoxyglucose (FDG)-PET imaging carried out with the current standard techniques for assessment of urinary tract cancers have been reported to be less than satisfactory because of the urinary excretion of the tracer. Aims: To investigate the role of dual-phase FDG-PET/CT in the restaging of invasive cancers of the urinary bladder, with delayed imaging after forced diuresis and oral hydration as the scanning protocol. Settings and Design: FDG-PET has been considered to be of limited value for the detection of urinary tract cancers because of interference by the FDG excreted in urine. We investigated the efficacy of delayed FDG-PET/CT in the restaging of invasive bladder cancer, with imaging performed after intravenous (IV) administration of a potent diuretic and oral hydration. Materials and Methods: Twenty-nine patients with invasive cancer of the urinary bladder were included in this study. Patients were divided into two groups: Group I (22 patients) included cases with invasive bladder cancer who had not undergone cystectomy and group II (seven patients) included cases with invasive bladder cancer who had undergone cystectomy and urinary diversion procedure. All patients underwent FDG-PET/CT scan from the skull base to the mid-thighs 60 min after IV injection of 370 mega-Becquerel (MBq) of FDG. Additional delayed images were acquired 60-90 min after IV furosemide and oral hydration. PET/CT data were analyzed as PET and CT images studied separately as well as fused PET/CT images and the findings were recorded. The imaging findings were confirmed by cystoscopy, biopsy or follow-up PET/CT. Results: The technique was successful in achieving adequate washout of urinary FDG and overcame the problems posed by the excess FDG in the urinary tract. Hypermetabolic lesions could be easily detected by PET and precisely localized to the bladder wall, perivesical region and pelvic lymph nodes. PET/CT delayed images were able to demonstrate 16 intravesical lesions (in 13 patients), with excellent clarity. Lymph node metastases were detected in a total of six patients. Of these, in two patients, FDG-avid lymph nodes were evident only in the delayed images. The information provided by the postdiuretic delayed images changed the PET/CT interpretation in 14 patients of invasive bladder cancer: Recurrent bladder lesions were identified in 12 patients, pelvic lymph node metastasis (only) in one patient and bladder lesion as well as lymph node metastasis in one patient. Distant metastases were detected by PET/CT in two cases. CT scan was false-negative for early recurrence in the bladder wall for seven of 16 lesions. CT also showed two false-positive lesions. There were no false-positives with PET. Conclusions: Detection of recurrent disease in cases of invasive bladder cancer can be significantly improved by using FDG-PET/CT, with delayed imaging following forced diuresis and oral hydration. Composite PET/CT is superior to CT alone for the restaging of invasive bladder cancers.
机译:背景:据报道,目前的用于评估尿路癌的标准技术的 18 F-氟代脱氧葡萄糖(FDG)-PET成像结果差强人意。示踪剂。目的:探讨双相FDG-PET / CT在膀胱浸润性癌的再分期中的作用,以强制利尿和口服水合后的延迟成像作为扫描方案。设置和设计:由于尿中排出的FDG的干扰,FDG-PET被认为对尿路癌的检测价值有限。我们研究了延迟FDG-PET / CT在浸润性膀胱癌的再分期中的功效,并在静脉(IV)给予有效利尿剂和口服水合后进行了成像。材料与方法:本研究纳入了29例膀胱浸润性癌患者。患者分为两组:第一组(22例)包括未进行膀胱切除术的浸润性膀胱癌病例,第二组(七例)包括已进行膀胱切除术和尿液转移手术的浸润性膀胱癌病例。在静脉注射370兆Becquerel(MBq)的FDG后,所有患者均从颅底至大腿中部进行了FDG-PET / CT扫描。在静脉注射速尿和口服水合后60-90分钟,获得了另外的延迟图像。对PET / CT数据进行分析,分别研究PET和CT图像以及融合的PET / CT图像,并记录发现结果。影像学检查结果通过膀胱镜检查,活检或随访PET / CT得以证实。结果:该技术成功地实现了尿FDG的充分冲洗,克服了尿道中过量FDG带来的问题。可以通过PET轻松检测到代谢亢进的病变,并将其精确定位在膀胱壁,淋巴结区域和盆腔淋巴结。 PET / CT延迟图像能够显示出16个膀胱内病变(在13例患者中),并且清晰度极高。在总共六名患者中检测到淋巴结转移。其中,在两名患者中,FDG-avid淋巴结仅在延迟图像中可见。利尿后延迟影像提供的信息改变了14例浸润性膀胱癌患者的PET / CT解释:12例患者发现了膀胱复发性病变,一名患者发现了盆腔淋巴结转移(仅),膀胱病变以及淋巴结转移一位病人PET / CT检测到远处转移2例。 16处病变中有7处的CT扫描显示膀胱壁的早期复发为假阴性。 CT还显示出两个假阳性病变。 PET没有假阳性。结论:FDG-PET / CT可显着改善浸润性膀胱癌复发疾病的检测,并在强制利尿和口服补液后延迟影像学检查。复合PET / CT在重新诊断浸润性膀胱癌方面优于单独使用CT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号